ALKERAN (Apo-Pharma USA, Inc)


Welcome to the PulseAid listing for the ALKERAN drug offered from Apo-Pharma USA, Inc. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Apo-Pharma USA, Inc
NON-PROPRIETARY NAME: melphalan
SUBSTANCE NAME: MELPHALAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-01-01
END MARKETING DATE: 0000-00-00


ALKERAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionALKERAN from Apo-Pharma USA, Inc
LABELER NAME: Apo-Pharma USA, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/1)
START MARKETING DATE: 2011-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52609-0001_aa854011-1753-3cf6-d279-5f179d6b317a
PRODUCT NDC: 52609-0001
APPLICATION NUMBER: NDA014691

Other MELPHALAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Melphalan
Apo-Pharma USA, IncALKERAN
Par Pharmaceutical, Inc.Melphalan Hydrochloride